Ranking · Winter 2022 · Healthcare · Drug Discovery and Delivery

WhiteLab Genomics

Unleash the potential of genomic medicine using AI

3.8%

odds of being acquired in the next two years

0.6× the average (6.8%)

#4166 of 4,339 active YC companies · top 97%

Team of 52 · Paris, Île-de-France, France

Raises the odds

↑ rewrote its description in the last six months

↑ based in Remote

Lowers the odds

↓ industry: Healthcare

↓ tag: Artificial Intelligence

↓ sector: Drug Discovery and Delivery

From the model: how this company's profile compares with companies that were and weren't acquired since 2024. How it works.

Signals brief

ExitOdds reads WhiteLab Genomics's website and YC profile; Contextrie keeps the passages that bear on an acquisition, and every signal quotes its source.

3 free briefs left today

whitelabgx.com YC profile

Statistical estimate from public directory data as of 2026-10-07; it can't see revenue, funding or talks. Not investment advice. ExitOdds is independent and not affiliated with Y Combinator.

Built with open source on GitHub